FR2204421A1 - - Google Patents
Info
- Publication number
- FR2204421A1 FR2204421A1 FR7338282A FR7338282A FR2204421A1 FR 2204421 A1 FR2204421 A1 FR 2204421A1 FR 7338282 A FR7338282 A FR 7338282A FR 7338282 A FR7338282 A FR 7338282A FR 2204421 A1 FR2204421 A1 FR 2204421A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10777672A JPS5443570B2 (en) | 1972-10-27 | 1972-10-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2204421A1 true FR2204421A1 (en) | 1974-05-24 |
FR2204421B1 FR2204421B1 (en) | 1977-09-09 |
Family
ID=14467713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7338282A Expired FR2204421B1 (en) | 1972-10-27 | 1973-10-26 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS5443570B2 (en) |
DE (1) | DE2353797A1 (en) |
FR (1) | FR2204421B1 (en) |
GB (1) | GB1450960A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2441389A1 (en) * | 1978-11-20 | 1980-06-13 | Chinoin Gyogyszer Es Vegyeszet | CYCLODEXTRIN-CAMOMILE INCLUSION COMPLEXES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SUCH COMPLEXES |
EP0399902A1 (en) * | 1989-05-24 | 1990-11-28 | Rhone-Poulenc Sante | Porous pharmaceutical form and process to prepare it |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS536416A (en) * | 1976-07-01 | 1978-01-20 | Emu Esu Shii Yuugen | 55fluorouracli inclusion compound |
JPS53133623A (en) * | 1977-04-21 | 1978-11-21 | Fujimoto Seiyaku Kk | Medical preparation including antiicholine active medicine by cyclodextrin analogue |
EP0056065B1 (en) * | 1981-01-10 | 1984-04-04 | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. | Stabilized prostaglandin tablets for topical use with regulated dissolving speed and process for preparing them |
JPS5830032B2 (en) * | 1981-02-18 | 1983-06-27 | 呉羽化学工業株式会社 | Bifidus bacteria growth agent |
DE3304864A1 (en) * | 1983-02-12 | 1984-08-16 | Bayer Ag, 5090 Leverkusen | Adsorbates of prostaglandins |
US4596795A (en) * | 1984-04-25 | 1986-06-24 | The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services | Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives |
HU196306B (en) * | 1985-04-01 | 1988-11-28 | Chinoin Gyogyszer Es Vegyeszet | New dusting powders comprising bioactive material and process for preparing the same |
JPH075464B2 (en) * | 1985-07-08 | 1995-01-25 | 中外製薬株式会社 | Stable nicorandil formulation |
US4837239A (en) * | 1985-08-23 | 1989-06-06 | Syntex (U.S.A.) Inc. | Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins |
US5684121A (en) * | 1994-12-06 | 1997-11-04 | Isp Investments Inc. | N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution |
JPWO2006075690A1 (en) * | 2005-01-14 | 2008-06-12 | 小野薬品工業株式会社 | Stable pharmaceutical composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3504019A (en) * | 1967-02-20 | 1970-03-31 | American Home Prod | Prostaglandin purification process |
US3644638A (en) * | 1970-08-24 | 1972-02-22 | American Home Prod | Compositions and methods for relieving bronchial spasm with prostanoic acids and esters |
FR2100745A1 (en) * | 1970-06-10 | 1972-03-24 | Ono Pharmaceutical Co |
-
1972
- 1972-10-27 JP JP10777672A patent/JPS5443570B2/ja not_active Expired
-
1973
- 1973-10-26 GB GB5004773A patent/GB1450960A/en not_active Expired
- 1973-10-26 FR FR7338282A patent/FR2204421B1/fr not_active Expired
- 1973-10-26 DE DE19732353797 patent/DE2353797A1/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3504019A (en) * | 1967-02-20 | 1970-03-31 | American Home Prod | Prostaglandin purification process |
FR2100745A1 (en) * | 1970-06-10 | 1972-03-24 | Ono Pharmaceutical Co | |
US3644638A (en) * | 1970-08-24 | 1972-02-22 | American Home Prod | Compositions and methods for relieving bronchial spasm with prostanoic acids and esters |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2441389A1 (en) * | 1978-11-20 | 1980-06-13 | Chinoin Gyogyszer Es Vegyeszet | CYCLODEXTRIN-CAMOMILE INCLUSION COMPLEXES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SUCH COMPLEXES |
EP0399902A1 (en) * | 1989-05-24 | 1990-11-28 | Rhone-Poulenc Sante | Porous pharmaceutical form and process to prepare it |
FR2647343A1 (en) * | 1989-05-24 | 1990-11-30 | Rhone Poulenc Sante | NOVEL POROUS PHARMACEUTICAL FORM AND PREPARATION THEREOF |
Also Published As
Publication number | Publication date |
---|---|
FR2204421B1 (en) | 1977-09-09 |
JPS5443570B2 (en) | 1979-12-20 |
DE2353797A1 (en) | 1974-05-09 |
JPS4966816A (en) | 1974-06-28 |
GB1450960A (en) | 1976-09-29 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |